Pharmaceutical ingredients, construction materials among areas of focus for China's enhanced antitrust enforcement
MLex Summary: The Antimonopoly Bureau of China’s State Administration for Market Regulation will enhance antitrust enforcement in the sectors for pharmaceutical ingredients and construction materials, as well as in other industries...To view the full article, register now.
Already a subscriber? Click here to view full article